0

523144

MEDICAPQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDI-CAPS LTD. Share Price Update

As of the latest trading session, MEDI-CAPS LTD. is trading at ₹30.34, up by ₹1.08 or 3.69% from its previous close. The stock has moved between ₹29.10 and ₹31.65 today. Over the past year, the stock has delivered a return of -32.04%. In the last month, it has returned -9.57%.

Investment Returns

Over 1 Month -9.57% Over 3 Months 22.32% Over 6 Months -13.04% Over 1 Year -32.04%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDI-CAPS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 37.50
  • P/E Ratio (TTM) -266.00
  • Beta 1.02
  • Book Value / share 53.49
  • Return on equity 0.27%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.31
info icon alternate text

MEDI-CAPS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.51
Operating Expense 0.94
Net Profit -0.31
Net Profit Margin (%) -60.78
Earnings Per Share (EPS) -0.25
EBITDA -0.26
Effective Tax Rate (%) 3.03
Particulars DEC 2025 (Values in Cr)
Revenue 0.77
Operating Expense 0.63
Net Profit 0.29
Net Profit Margin (%) 37.66
Earnings Per Share (EPS) 0.23
EBITDA 0.35
Effective Tax Rate (%) 9.67
Particulars SEP 2025 (Values in Cr)
Revenue 1.00
Operating Expense 0.72
Net Profit 0.29
Net Profit Margin (%) 28.99
Earnings Per Share (EPS) 0.23
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.71
Net Profit -0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.32
EBITDA -0.36
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.88
Operating Expense 0.72
Net Profit 0.71
Net Profit Margin (%) 80.68
Earnings Per Share (EPS) 0.57
EBITDA 0.48
Effective Tax Rate (%) -61.36
Particulars MAR 2026 (Values in Cr)
Revenue 2.28
Operating Expense 3.01
Net Profit -0.14
Net Profit Margin (%) -6.14
Earnings Per Share (EPS) -0.11
EBITDA 0.07
Effective Tax Rate (%) -8.33
Particulars MAR 2025 (Values in Cr)
Revenue 2.37
Operating Expense 2.69
Net Profit 0.56
Net Profit Margin (%) 23.62
Earnings Per Share (EPS) 0.45
EBITDA 0.44
Effective Tax Rate (%) -93.10
Particulars MAR 2024 (Values in Cr)
Revenue 6.93
Operating Expense 2.49
Net Profit 3.89
Net Profit Margin (%) 56.13
Earnings Per Share (EPS) 3.12
EBITDA 4.99
Effective Tax Rate (%) 19.46
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.49
Net Profit 0.15
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.35
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.67
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA 0.03
Effective Tax Rate (%) -16.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 97.25
ROE % -1.94
ROCE % -2.11
Total Debt to Total Equity 0.00
EBITDA Margin -3.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 97.02
ROE % -2.03
ROCE % -1.16
Total Debt to Total Equity 0.00
EBITDA Margin 1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.09
ROE % 1.05
ROCE % 3.68
Total Debt to Total Equity 0.00
EBITDA Margin 12.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.23
ROE % 9.12
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 17.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.97
ROE % 11.38
ROCE % 11.42
Total Debt to Total Equity 0.00
EBITDA Margin 21.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 54.00
ROE % 0.27
ROCE % -0.13
Total Debt to Total Equity 0.00
EBITDA Margin 2.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.32
ROE % 6.10
ROCE % 7.57
Total Debt to Total Equity 0.00
EBITDA Margin 69.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.00
ROE % -0.80
ROCE % -0.62
Total Debt to Total Equity 0.00
EBITDA Margin -290.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49.15
ROE % -0.82
ROCE % -0.87
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.89
ROE % 0.02
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 125.42
Total Liabilities 125.42
Total Equity 121.27
Share Outstanding 1
Price to Book Ratio 0.77
Return on Assets (%) -0.45
Return on Capital (%) -0.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 127.28
Total Liabilities 127.28
Total Equity 120.98
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) -1.76
Return on Capital (%) -1.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 125.98
Total Liabilities 125.98
Total Equity 118.57
Share Outstanding 1
Price to Book Ratio 0.71
Return on Assets (%) 1.39
Return on Capital (%) 1.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 9.75
Total Assets 130.35
Total Liabilities 130.35
Total Equity 116.25
Share Outstanding 1
Price to Book Ratio 1.01
Return on Assets (%) 7.73
Return on Capital (%) 8.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.80
Total Assets 114.81
Total Liabilities 114.81
Total Equity 104.71
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) 9.69
Return on Capital (%) 10.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 68.02
Total Liabilities 68.02
Total Equity 67.34
Share Outstanding 1
Price to Book Ratio 0.77
Return on Assets (%) 0.81
Return on Capital (%) 0.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 68.09
Total Liabilities 68.09
Total Equity 66.48
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) 5.71
Return on Capital (%) 5.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 61.62
Total Liabilities 61.62
Total Equity 61.10
Share Outstanding 1
Price to Book Ratio 0.71
Return on Assets (%) 0.23
Return on Capital (%) 0.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 61.80
Total Liabilities 61.80
Total Equity 61.28
Share Outstanding 1
Price to Book Ratio 1.01
Return on Assets (%) -0.06
Return on Capital (%) -0.06
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 62.63
Total Liabilities 62.63
Total Equity 60.96
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) -0.17
Return on Capital (%) -0.18
Particulars MAR 2025 (Values in Cr)
Net Income -0.84
Cash from Operations 4.81
Cash from Investing -4.97
Cash from Financing 0.00
Net change in Cash 0.09
Free Cash Flow 5.13
Particulars MAR 2024 (Values in Cr)
Net Income -1.24
Cash from Operations 7.94
Cash from Investing -7.73
Cash from Financing 0.00
Net change in Cash -0.79
Free Cash Flow 8.29
Particulars MAR 2023 (Values in Cr)
Net Income 4.92
Cash from Operations -3.02
Cash from Investing -2.56
Cash from Financing 0.00
Net change in Cash -8.64
Free Cash Flow -1.86
Particulars MAR 2022 (Values in Cr)
Net Income 10.05
Cash from Operations 7.02
Cash from Investing -4.07
Cash from Financing 0.00
Net change in Cash 2.94
Free Cash Flow 9.81
Particulars MAR 2021 (Values in Cr)
Net Income 11.23
Cash from Operations 15.31
Cash from Investing -9.69
Cash from Financing -0.06
Net change in Cash 5.55
Free Cash Flow 17.57
Particulars MAR 2025 (Values in Cr)
Net Income 0.28
Cash from Operations 1.59
Cash from Investing -1.84
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 1.67
Particulars MAR 2024 (Values in Cr)
Net Income 4.82
Cash from Operations 4.04
Cash from Investing -3.08
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 4.04
Particulars MAR 2023 (Values in Cr)
Net Income 0.25
Cash from Operations -2.59
Cash from Investing 1.85
Cash from Financing 0.00
Net change in Cash -0.74
Free Cash Flow -2.59
Particulars MAR 2022 (Values in Cr)
Net Income -0.06
Cash from Operations -0.95
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow -0.95
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 2.23
Cash from Investing -2.18
Cash from Financing -0.06
Net change in Cash -0.01
Free Cash Flow 2.23
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADITYA BIRLA REAL ESTATE LIMIT 1251.55 0.00 3.77 13979.27 1080.10 2535.00
ELPRO INTERNATIONAL LTD 167.85 32.53 1.40 2844.71 71.20 178.00
FORBES & COMPANY LTD. 316.15 30.40 2.04 407.83 301.90 477.00
GOLDEN TOBACCO LIMITED 40.25 13.37 -0.33 70.88 36.00 60.90
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
SANATHNAGAR ENTERPRISES LIMITE 36.70 114.69 -0.93 11.56 29.01 54.33
BARODA RAYON CORPORATION LTD. 126.00 14.22 0.73 288.68 100.10 175.80
ADITYA BIRLA REAL ESTATE LIMIT 1251.55 91.42 2.97 13979.27 1080.10 2535.00
ELPRO INTERNATIONAL LTD 167.85 85.64 1.35 2844.71 71.20 178.00

MEDI-CAPS LTD. shareholding pattern

Holding
48.61%
51.36%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDI-CAPS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
30.11 2.90 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 28.80
  • 26 Days 28.50
  • 10 Days 28.50
  • 50 Days 28.10
  • 12 Days 28.50
  • 100 Days 28.70
  • 20 Days 28.50
  • 200 Days 31.90
30.25 PIVOT
First Support 27.51 First Resistance 32.01 Second Support 25.75 Second Resistance 34.75 Third Support 23.01 Third Resistance 36.51
RSI 52.69 ADX 15.77 MACD 0.05 Williams % R -63.58 Commodity Channel Index (CCI) 27.43
Date 2026-06-01 Week 4336.00 Same Day 1365.00 Month 4753.00
1 Year 1.02 3 Year 0.71
Over 1 Month
-9.57% down
Over 1 Year
-32.04% down
Over 3 Months
22.32% down
Over 3 Years
-7.93% down
Over 6 Months
-13.04% down
Over 5 Years
-7.51% down

MEDI-CAPS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2012 1.5 Final 24 Sep 2012 Equity shares
22 Sep 2011 1.5 Final 24 Sep 2011 Equity shares
22 Sep 2010 1.5 Final 24 Sep 2010 Equity shares
24 Sep 2009 1.5 Final 28 Sep 2009 Equity shares
24 Sep 2008 1.5 Final 26 Sep 2008 Equity shares
20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
21 Sep 2006 0.0 Final 25 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 26 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
20 Mar 2013 19 Mar 2013 3:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medi Caps Ltd?

Answer Field

Medi Caps Ltd share price is for NSE ₹ 11.00 & for BSE ₹ 30.11 as on Jun 02 2026 03:23 PM.

What is the Market Cap of Medi Caps Ltd Share?

Answer Field

The market cap of Medi Caps Ltd for NSE ₹ 0.00 & for BSE ₹ 37.50 as on Jun 02 2026 03:23 PM.

What is the 52 Week High and Low of Medi Caps Ltd?

Answer Field

The 52 Week High and Low of Medi Caps Ltd for NSE is ₹ 11.00 and ₹ 0.00 and for BSE is ₹ 46.99 and ₹ 21.00.

What is 1 year return for Medi Caps Ltd?

Answer Field

The 1 year returns on the stock has been -32.04%.

What is the P/E Ratio of Medi Caps Ltd Share?

Answer Field

As on Jun 02 2026 03:23 PM the price-to-earnings (PE) ratio for Medi Caps Ltd share is -266.00.

What is the PB ratio of Medi Caps Ltd Share?

Answer Field

As on Jun 02 2026 03:23 PM, the price-to-book (PB) ratio for Medi Caps Ltd share is 53.49.

How to Buy Medi Caps Ltd Share?

Answer Field

You can trade in Medi Caps Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medi Caps Ltd Share on Bajaj Broking App?

Answer Field

To buy Medi Caps Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medi Caps Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|